Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Anne Sofie Astrup"'
Autor:
Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter Karl Jacobsen, Amra Ciric Alibegovic, Ida Parving, Lotte Pietraszek, Merete Frandsen, Peter Rossing, Hans-Henrik Parving, Allan Arthur Vaag
Publikováno v:
PLoS ONE, Vol 3, Iss 10, p e3363 (2008)
Despite intensive insulin treatment, many patients with type-1 diabetes (T1DM) have longstanding inadequate glycaemic control. Metformin is an oral hypoglycaemic agent that improves insulin action in patients with type-2 diabetes. We investigated the
Externí odkaz:
https://doaj.org/article/3dcf5adfad684ed5a0fd2f09f2ddfa78
Autor:
H. H. Parving, Peter Rossing, Anne Sofie Astrup, K. J. Schjoedt, Lise Tarnow, Peter Riis Hansen, Stine Elkjaer Nielsen, Maria Lajer
Publikováno v:
Diabetic Medicine. 27:1144-1150
Diabet. Med. 27, 1144–1150 (2010) Abstract Aims Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in Type 1 diabetic patients with different level
Autor:
H. H. Parving, Amra Ciric Alibegovic, Peter Hovind, Anne Sofie Astrup, Søren S Lund, Peter Karl Jacobsen, Allan Vaag, M. Frandsen, Peter Rossing, Lise Tarnow, Lotte Pietraszek, I. Parving
Publikováno v:
Diabetes, Obesity and Metabolism. 11:966-977
Background In addition to its glucose-lowering effect, metformin treatment has been suggested to improve lipidaemia in patients with type 2 diabetes. In contrast, in patients with type 1 diabetes (T1DM), information about the effect of metformin trea
Autor:
Hans-Henrik Parving, K. J. Schjoedt, Maria Lajer, Tsuneharu Baba, Lise Tarnow, Peter Rossing, Anne Sofie Astrup, Takeshi Sugaya, Stine Elkjaer Nielsen
Publikováno v:
Diabetes Care
OBJECTIVE We studied tubular and glomerular damage in type 1 diabetic patients by measuring urinary–liver fatty acid binding protein (U-LFABP) and albuminuria. Subsequently, we evaluated the effect of ACE inhibition on U-LFABP in patients with diab
Autor:
Coen D.A. Stehouwer, Casper G. Schalkwijk, Lise Tarnow, Lotte Pietraszek, Hans-Henrik Parving, Anne Sofie Astrup, Peter Rossing
Publikováno v:
Diabetes Care. 31:1170-1176
OBJECTIVE—We evaluated the association of biomarkers of endothelial dysfunction and inflammation with all-cause mortality and cardiovascular mortality and morbidity and decline in glomerular filtration rate (GFR) in type 1 diabetic patients. RESEAR
Autor:
Peter Riis Hansen, Peter Rossing, Anne Sofie Astrup, M. Christiansen, H.-H. Parving, Lise Tarnow
Publikováno v:
Diabetic Medicine. 24:1381-1385
Aim Pregnancy-associated plasma protein A (PAPP-A) has been implicated in the aetiology of acute coronary syndromes and carotid and peripheral artherosclerosis. Diabetic nephropathy is characterized by increased cardiovascular risk. We investigated t
Autor:
Hans-Henrik Parving, Cheryl Simonsen, René M. Botnar, Lotte Pietraszek, Lise Tarnow, Peter Riis Hansen, Anne Sofie Astrup, Niels Trolle Andersen, Won Yong Kim, Matthias Stuber, Warren J. Manning, Erling Falk
Publikováno v:
Kim, W Y, Astrup, A S, Stuber, M, Tarnow, L, Falk, E, Botnar, R M, Simonsen, C, Pietraszek, L, Hansen, P R, Manning, W J, Andersen, N T & Parving, H-H 2007, ' Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy ', Circulation, vol. 115, no. 2, pp. 228-235 .
Background— Patients with type 1 diabetes and nephropathy maintain an excess cardiovascular mortality compared with diabetic patients with normoalbuminuria. We sought to evaluate coronary and aortic atherosclerosis in a cohort of asymptomatic type
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 65:73-79
Placental growth factor (PlGF) is up-regulated in early and advanced atherosclerotic lesions, acts as a primary inflammatory instigator of atherosclerotic plaque instability, and may be an independent biomarker of adverse outcome in patients with acu
Autor:
Anne Sofie, Astrup
Publikováno v:
Danish medical bulletin. 58(8)
Autor:
Hans-Henrik Parving, Nadja Pedersen, Won Yong Kim, Anne Sofie Astrup, Lise Tarnow, Thomas Mandrup-Poulsen, Peter Karl Jacobsen, Nils Billestrup, Maria Lajer, Henrik Reinhard, Peter Rossing
Publikováno v:
Reinhard, H, Jacobsen, P K, Lajer, M, Tarnow, L, Astrup, A S, Kim, W Y, Pedersen, N, Billestrup, N, Mandrup-Poulsen, T, Parving, H-H & Rossing, P 2011, ' Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy ', Nephron Clinical Practice, vol. 118, no. 3, pp. c309-14 . https://doi.org/10.1159/000322667
A decrease in the number and dysfunction of endothelial progenitor cells (EPC) may increase the risk for progression of cardiovascular disease (CVD) in type 1 diabetic patients with diabetic nephropathy (DN). Our aim was to evaluate EPC numbers in as